Last updated on November 2016

A STUDY TO EVALUATE A PANEL OF BLOOD BIOMARKERS FOR USE IN PATIENTS UNDERGOING EVALUATION FOR LUNG CANCER, ONC-LN-04


Brief description of study

A STUDY TO EVALUATE A PANEL OF BLOOD BIOMARKERS FOR USE IN PATIENTS UNDERGOING EVALUATION FOR LUNG CANCER, ONC-LN-04

Detailed Study Description

Experimental tests, such as those used on the blood collected in this research study are also known as “investigational.” This means the tests have not been approved by the U.S. Food and Drug Administration (FDA).

In this research study, the accuracy of these blood tests will be determined by comparing the results with other tests as determined by your study doctor.

Clinical Study Identifier: TX146413

Find a site near you

Start Over

Reading Hospital Clinical Trials Office

301 South 7th Avenue, Suite 120 West Reading, PA USA
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.